To include your compound in the COVID-19 Resource Center, submit it here.

Capstone Therapeutics, LipimetiX deal

Capstone and LipimetiX formed a 60/40 JV, LipimetiX Development

Read the full 97 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE